It looks like there could be a setback for CRISPR-Cas9 as a gene therapy option for humans. Last year ended well for the gene-editing tool, and we got one step…
The Ivory Embassy wishes all of you a happy new year! The doors to the Embassy are finally reopened after a well-needed Christmas break, and we know exactly what you…
Red wine cures cancer! That caught your attention, didn’t it? It’s just an example of titles or statements that can quickly spread on social media and cause confusion, in addition…
The Nobel Prizes were awarded yesterday, December 10th. Let’s have a closer look at the prize awarded in Chemistry and how the laureates work helped us to literally look at…
The Nobel Prize Award ceremony is near. On December 10th, the Nobel laureates of 2017 will be presented in Stockholm, Sweden. Let's talk Nobel Prize in Physiology or Medicine and your…
Last week it was settled: the European Medicines Agency (EMA) will be moving from London to Amsterdam. Brexit was the classic homewrecker in this story, forcing a 12-year relationship to…
CRISPR-Cas is the tool that is on people’s lips right now, not only scientists' (in our opinion, at least). The media discusses designer babies, disease-resistant crops, and many other applications.…
Before jumping into CRISPR technology, we must learn how researchers cut DNA through gene editing tools. How do these tools differ from each other? The chances are that you have…
How much? I imagine that question came up eventually at one of the meetings of whichever team decides pricing strategies at Novartis. And they came up with an answer: 475000 $. Four…
Our responsibility to inform - we are part of the ivory tower Do a quick scroll in the newsfeed of your preferred social media sites. Stop scrolling once you find…